X-119834909-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_080632.3(UPF3B):c.1421T>A(p.Ile474Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080632.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UPF3B | ENST00000276201.7 | c.1421T>A | p.Ile474Asn | missense_variant | Exon 11 of 11 | 1 | NM_080632.3 | ENSP00000276201.3 | ||
UPF3B | ENST00000345865.6 | c.1382T>A | p.Ile461Asn | missense_variant | Exon 10 of 10 | 1 | ENSP00000245418.2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The alteration results in an amino acid change:_x000D_ _x000D_ The c.1421T>A (p.I474N) alteration is located in coding exon 11 of the UPF3B gene. This alteration results from a T to A substitution at nucleotide position 1421, causing the isoleucine (I) at amino acid position 474 to be replaced by an asparagine (N). The alteration is not observed in healthy cohorts:_x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the UPF3B c.1421T>A alteration was not observed, with coverage at this site. The altered amino acid is not conserved throughout evolution:_x000D_ _x000D_ The p.I474 amino acid is not conserved in available vertebrate species. The alteration is predicted benign by in silico models:_x000D_ _x000D_ The p.I474N alteration is predicted to be benign by Polyphen and tolerated by SIFT in silico analyses. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at